An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...

Inspire Medical Systems, Inc. ( NYSE: INSP) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive ...

Medicare covers sleep tests for certain conditions such as sleep apnea, narcolepsy, or parasomnia, but limitations may apply.

Medicare covers sleep tests if you experience clinical signs and symptoms of sleep apnea, narcolepsy, or parasomnia. But there are some limitations depending on what condition is being screened for.

Inspire Medical Systems ( INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

Inspire expects full-year earnings to be $2.10 to $2.20 per share, with revenue in the range of $940 million to $955 million. This story was generated by Automated Insights ( ...

Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...

Central sleep apnea is a sleep disorder in which your brain’s signaling to your body that controls your breathing is disrupted. Central sleep apnea is a sleep disorder in which you briefly stop ...

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.